These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Platelet activation in cystic fibrosis. O'Sullivan BP; Linden MD; Frelinger AL; Barnard MR; Spencer-Manzon M; Morris JE; Salem RO; Laposata M; Michelson AD Blood; 2005 Jun; 105(12):4635-41. PubMed ID: 15705796 [TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy of the ion transport defect in cystic fibrosis: role of purinergic receptor agonists and other potential therapeutics. Kunzelmann K; Mall M Am J Respir Med; 2003; 2(4):299-309. PubMed ID: 14719996 [TBL] [Abstract][Full Text] [Related]
6. Important role of platelets in modulating endotoxin-induced lung inflammation in CFTR-deficient mice. Zhao C; Su EM; Yang X; Gao Z; Li L; Wu H; Jiang Y; Su X PLoS One; 2013; 8(12):e82683. PubMed ID: 24367540 [TBL] [Abstract][Full Text] [Related]
7. Elevated Mirc1/Mir17-92 cluster expression negatively regulates autophagy and CFTR (cystic fibrosis transmembrane conductance regulator) function in CF macrophages. Tazi MF; Dakhlallah DA; Caution K; Gerber MM; Chang SW; Khalil H; Kopp BT; Ahmed AE; Krause K; Davis I; Marsh C; Lovett-Racke AE; Schlesinger LS; Cormet-Boyaka E; Amer AO Autophagy; 2016 Nov; 12(11):2026-2037. PubMed ID: 27541364 [TBL] [Abstract][Full Text] [Related]
8. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis. Stotland PK; Radzioch D; Stevenson MM Pediatr Pulmonol; 2000 Nov; 30(5):413-24. PubMed ID: 11064433 [TBL] [Abstract][Full Text] [Related]
10. Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response. Mattoscio D; Evangelista V; De Cristofaro R; Recchiuti A; Pandolfi A; Di Silvestre S; Manarini S; Martelli N; Rocca B; Petrucci G; Angelini DF; Battistini L; Robuffo I; Pensabene T; Pieroni L; Furnari ML; Pardo F; Quattrucci S; Lancellotti S; Davì G; Romano M FASEB J; 2010 Oct; 24(10):3970-80. PubMed ID: 20530751 [TBL] [Abstract][Full Text] [Related]
11. Iron Homeostasis and Inflammatory Status in Mice Deficient for the Cystic Fibrosis Transmembrane Regulator. Deschemin JC; Allouche S; Brouillard F; Vaulont S PLoS One; 2015; 10(12):e0145685. PubMed ID: 26709821 [TBL] [Abstract][Full Text] [Related]
12. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772 [TBL] [Abstract][Full Text] [Related]
13. The low PLC-δ1 expression in cystic fibrosis bronchial epithelial cells induces upregulation of TRPV6 channel activity. Vachel L; Norez C; Jayle C; Becq F; Vandebrouck C Cell Calcium; 2015 Jan; 57(1):38-48. PubMed ID: 25477137 [TBL] [Abstract][Full Text] [Related]
14. Down-regulation of the anti-inflammatory protein annexin A1 in cystic fibrosis knock-out mice and patients. Bensalem N; Ventura AP; Vallée B; Lipecka J; Tondelier D; Davezac N; Dos Santos A; Perretti M; Fajac A; Sermet-Gaudelus I; Renouil M; Lesure JF; Halgand F; Laprévote O; Edelman A Mol Cell Proteomics; 2005 Oct; 4(10):1591-601. PubMed ID: 16014420 [TBL] [Abstract][Full Text] [Related]
15. Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects. Kuk K; Taylor-Cousar JL Ther Adv Respir Dis; 2015 Dec; 9(6):313-26. PubMed ID: 26416827 [TBL] [Abstract][Full Text] [Related]